{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["10"],"submitter":["Lounis M"],"pubmed_abstract":["Healthcare workers were prioritized in vaccination campaigns globally because they are exposed to the highest risk of contamination by SARS-CoV-2. This study evaluated the self-reported post-vaccination side effects of inactivated (BBIBP-CorV and CoronaVac) and adenoviral vector-based (AZD1222, Gam-COVID-Vac and Ad26.COV2.S) vaccines among Algerian healthcare workers using a validated questionnaire. The final analysis included 721 healthcare workers, with a predominance of females (59.1%) and younger individuals 20-30 years old (39.4%). Less than half (49.1%) of the respondents reported at least one local side effect, while 53.8% reported at least one systemic side effect. These side effects were more prevalent among viral vector vaccinees than inactivated virus vaccinees. The most common "],"journal":["Frontiers in public health"],"pagination":["896343"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9149155"],"repository":["biostudies-literature"],"pubmed_title":["Side Effects of COVID-19 Inactivated Virus vs. Adenoviral Vector Vaccines: Experience of Algerian Healthcare Workers."],"pmcid":["PMC9149155"],"pubmed_authors":["Lounis M","Pokorna A","Klugarova J","Klugar M","Bencherit D","Aouissi HA","Oudjedi A","Riad A","Rais MA"],"additional_accession":[]},"is_claimable":false,"name":"Side Effects of COVID-19 Inactivated Virus vs. Adenoviral Vector Vaccines: Experience of Algerian Healthcare Workers.","description":"Healthcare workers were prioritized in vaccination campaigns globally because they are exposed to the highest risk of contamination by SARS-CoV-2. This study evaluated the self-reported post-vaccination side effects of inactivated (BBIBP-CorV and CoronaVac) and adenoviral vector-based (AZD1222, Gam-COVID-Vac and Ad26.COV2.S) vaccines among Algerian healthcare workers using a validated questionnaire. The final analysis included 721 healthcare workers, with a predominance of females (59.1%) and younger individuals 20-30 years old (39.4%). Less than half (49.1%) of the respondents reported at least one local side effect, while 53.8% reported at least one systemic side effect. These side effects were more prevalent among viral vector vaccinees than inactivated virus vaccinees. The most common ","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-22T11:50:15.331Z","creation":"2025-04-06T00:04:13.376Z"},"accession":"S-EPMC9149155","cross_references":{"pubmed":["35651866"],"doi":["10.3389/fpubh.2022.896343"]}}